Internal Reference Number: FOI_6413
Date Request Received: 04/01/2022 00:00:00
Date Request Replied To: 04/01/2022 00:00:00
This response was sent via: By Email
Request Summary: Clotting Disorders
Request Category: Researcher
Question Number 1: How many patients has your trust treated (for any medical condition) in the past 3 months with the following drugs: • Alphanate • Alprolix • BeneFIX • HaemateP • Idelvion • Refixia • Rixubis • Veyvondi • Voncento • Wilate • Willfact | |
Answer To Question 1: Section 38 refusal notice applied to all questions | |
Question Number 2: How many patients have been treated in the past 3 months with: • Gene therapy for Haemophilia B ONLY • Desmopressin for Von Willebrand Disease ONLY • Tranexamic Acid for Von Willebrand Disease ONLY | |
Answer To Question 2: Section 38 refusal notice applied to al questions | |
Question Number 3: Of the patients that were treated with Veyvondi in the past 3 months, how many patients received treatment: • During surgery • On-demand to treat bleeding episodes | |
Answer To Question 3: Section 38 refusal notice applied to all questions | |
Question Number 4: How many patients are registered with your Haemophilia Centre for: • Von Willebrand Disease – adult patients (age 18 or above) • Von Willebrand Disease – pediatric patients (age 17 or under) • Haemophilia B (any age) | |
Answer To Question 4: Section 38 refusal notice applied to all questions | |
To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¿´Æ¬Èí¼þ Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.